Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Agile Therapeutics Inc AGRX

Alternate Symbol(s):  AGXRW

Healthcare
Agile Therapeutics, Inc. is a women's healthcare company, which is engaged in fulfilling the unmet health needs of women. The Company’s sole approved product, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch. Twirla is a method of contraception for use in women of reproductive potential for whom a combined hormonal contraceptive is appropriate. Twirla is a... see more

Recent & Breaking News (OTCQB:AGRX)

Agile Therapeutics to Report Third Quarter 2021 Financial Results and Provide Business Update on Tuesday, November 2, 2021

GlobeNewswire October 22, 2021

Agile Therapeutics Applauds Congressional Chairs' Letter to Biden Administration Requesting Enforcement of Contraceptive Access Under Affordable Care Act

GlobeNewswire October 12, 2021

Agile Therapeutics Appoints Josephine Torrente to its Board of Directors

GlobeNewswire October 8, 2021

Agile Therapeutics Announces Pricing of $22,666,650 Underwritten Public Offering of Common Stock and Warrants

GlobeNewswire October 8, 2021

Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Warrants

GlobeNewswire October 7, 2021

Agile Therapeutics Announces Addition of Twirla® to a Preferred Drug Position on Medi-Cal Formulary

GlobeNewswire October 4, 2021

Agile Therapeutics Partners with Carli Lloyd, U.S. Women’s Soccer Star and Four-Time Olympian, to Bring Awareness to Women’s Health Topics

TheNewsWire September 28, 2021

Agile Therapeutics Partners with Carli Lloyd, U.S. Women's Soccer Star and Four-Time Olympian, to Bring Awareness to Women's Health Topics

GlobeNewswire September 28, 2021

Agile Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire September 7, 2021

Agile Therapeutics Partners with Telehealth Service, Pandia Health, to Increase Women's Access to Twirla® (levonorgestrel and ethinyl estradiol) transdermal system

GlobeNewswire August 20, 2021

Agile Therapeutics Reports Second Quarter 2021 Financial Results

GlobeNewswire July 26, 2021

50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

Accesswire July 8, 2021

Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021

GlobeNewswire July 1, 2021

50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

Accesswire June 23, 2021

Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference

GlobeNewswire May 26, 2021

Agile Therapeutics to Participate in Virtual Fireside Chat as Part of the 2021 RBC Capital Markets Global Healthcare Conference

GlobeNewswire May 12, 2021

Agile Therapeutics Reports First Quarter 2021 Financial Results

GlobeNewswire May 4, 2021

Agile Therapeutics Announces Presentation of Safety and Efficacy Data of Twirla® (Levonorgestrel and Ethinyl Estradiol) Transdermal System in Women of Differing BMI Categories at ACOG Annual Meeting

GlobeNewswire April 30, 2021

CORRECTING AND REPLACING -- Agile Therapeutics

GlobeNewswire April 20, 2021

Agile Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on Tuesday, May 4, 2020

GlobeNewswire April 20, 2021